Impact of pegylated filgrastim in comparison to filgrastim for patients with acute myeloid leukaemia (AML) on high-dose cytarabine (HIDAC) consolidation chemotherapy.
about
Refining the role of pegfilgrastim (a long-acting G-CSF) for prevention of chemotherapy-induced febrile neutropenia: consensus guidance recommendations.A phase I study of different doses and frequencies of pegylated recombinant human granulocyte-colony stimulating factor (PEG rhG-CSF) in patients with standard-dose chemotherapy-induced neutropenia.
P2860
Impact of pegylated filgrastim in comparison to filgrastim for patients with acute myeloid leukaemia (AML) on high-dose cytarabine (HIDAC) consolidation chemotherapy.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Impact of pegylated filgrastim ...... C) consolidation chemotherapy.
@en
Impact of pegylated filgrastim ...... s with acute myeloid leukaemia
@nl
type
label
Impact of pegylated filgrastim ...... C) consolidation chemotherapy.
@en
Impact of pegylated filgrastim ...... s with acute myeloid leukaemia
@nl
prefLabel
Impact of pegylated filgrastim ...... C) consolidation chemotherapy.
@en
Impact of pegylated filgrastim ...... s with acute myeloid leukaemia
@nl
P2093
P2860
P1476
Impact of pegylated filgrastim ...... C) consolidation chemotherapy.
@en
P2093
Ai Leen Ang
Gee Chuan Wong
Ling Ling Yueh
Richard Yiu
Yeow Tee Goh
Yvonne Loh
P2860
P2888
P304
P356
10.1007/S00520-014-2417-7
P577
2014-08-27T00:00:00Z